We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LZ:NASDAQLegalZoom.com, Inc. Analysis

Data as of 2026-04-16 - not real-time

$6.24

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

LegalZoom (LZ) is trading at $6.24, comfortably above its 20‑day SMA of 5.92 but still below the 50‑day SMA of 6.48, indicating short‑term momentum while longer‑term bias remains bearish. The MACD histogram is positive and the signal is deemed bullish, yet the overall trend is classified as bearish and volatility is elevated at over 44% on a 30‑day basis. Valuation metrics are mixed: the trailing P/E of 78 dwarfs the industry average of 30.9, but the forward P/E of 7.75 and a DCF‑derived fair value of roughly $33 suggest substantial upside. Revenue is growing at a healthy 17.7% YoY with a solid gross margin of 66%, though profitability is thin, reflected by a net margin of just 2%. The balance sheet is strong, with $203 M in cash versus $14 M of debt, and free cash flow of $199 M supporting the business's liquidity. Analyst consensus is neutral (hold) with a median price target of $8.5, implying a potential upside of about 36% from current levels. Recent material news includes a Barclays downgrade to “Underweight” and a new survey highlighting compliance hurdles for small businesses, both of which add short‑term pressure.
Looking ahead, the company’s forward earnings trajectory is compelling, driven by a 33% share of small‑business owners citing compliance as a barrier to growth—an opportunity that aligns with LegalZoom’s core services. The strong cash generation and low leverage (debt‑to‑equity under 9%) provide a cushion against the high beta of 1.32 and the sector’s regulatory exposure. While the stock’s volatility and recent downgrade temper near‑term optimism, the long‑term outlook remains positive given secular demand for online legal solutions, a robust revenue growth profile, and a valuation gap relative to its DCF fair value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near resistance at $6.40
  • Barclays downgrade to Underweight
  • Elevated 30‑day volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Forward P/E of 7.75 indicating earnings acceleration
  • DCF fair value suggesting substantial upside
  • Revenue growth of 17.7% with strong cash generation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Secular demand for compliance and legal services among small businesses
  • Low leverage and strong free cash flow
  • Undervaluation relative to intrinsic DCF estimate

Key Metrics & Analysis

Financial Health

Revenue Growth17.70%
Profit Margin2.04%
P/E Ratio78.0
ROE11.64%
ROA1.83%
Debt/Equity8.36
P/B Ratio6.4
Op. Cash Flow$178.2M
Free Cash Flow$199.2M
Industry P/E30.9

Technical Analysis

TrendBearish
RSI52.7
Support$5.28
Resistance$6.40
MA 20$5.92
MA 50$6.48
MA 200$9.02
MACDBullish
VolumeIncreasing
Fear & Greed Index88.98

Valuation

Fair Value$32.84
Target Price$8.71
Upside/Downside39.65%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.32
Volatility44.36%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.